“Bevacizumab Plus Chemotherapy as First-Line Treatment for Patients with Metastatic Colorectal Cancer: Results from a Spanish Observational Study” (2013) Journal of Analytical Oncology, 2(3), pp.  128–134. doi:10.6000/1927-7229.2013.02.03.1.